Pemphigus and Bullous Pemphigoid Following COVID-19 Vaccination: A Systematic Review
Viruses · 09.12.2024 · 16 (12) · 1896
DOI: 10.3390/v16121896 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Viruses, online erschienen am 09.12.2024. Verfasst von Fabrizio Martora und 6 weiteren Autor:innen. Beteiligte Einrichtung: Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131 Napoli, Italy. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Pemphigoid, Bullous, Pemphigus. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The COVID-19 pandemic has encouraged the rapid development and licensing of vaccines against SARS-CoV-2. Currently, numerous vaccines are available on a global scale and are based on different mechanisms of action, including mRNA technology, viral vectors, inactive viruses, and subunit particles. Mass vaccination conducted worldwide has highlighted the potential development of side effects, including ones with skin involvement. This review synthesizes data from 62 manuscripts, reporting a total of 142 cases of autoimmune blistering skin diseases (AIBDs) following COVID-19 vaccination, comprising 59 cases of pemphigus and 83 cases of bullous pemphigoid. Among the 83 bullous pemphigoid cases, 78 were BP, with additional cases including 2 oral mucous membrane pemphigoid, 1 pemphigoid gestationis, 1 anti-p200 BP, and 1 dyshidrosiform BP. The mean age of affected individuals was 72 ± 12.7 years, with an average symptom onset of 11 ± 10.8 days post-vaccination. Notably, 59% of cases followed vaccination with BNT162b2 (Pfizer-BioNTech), 51.8% were new diagnoses, and 45.8% occurred after the second dose. The purpose of our review is to analyze the cases of pemphigus and bullous pemphigoid associated with COVID-19 vaccination and to investigate the pathogenetic mechanisms underlying the new development or flare-up of these diseases in association with vaccination. Our results show that the association between COVID-19 vaccines and AIBDs is a possible event.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131 Napoli, Italy.
- Department of Health Sciences, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy.
ORCID-Profile: Fabrizio Martora, Teresa Battista, Luca Potestio, Maddalena Napolitano, Cataldo Patruno, Matteo Megna
Zitieren
APA
Martora, F., Battista, T., Potestio, L., Napolitano, M., Patruno, C., Megna, M., & D'Agostino, M. (2024). Pemphigus and Bullous Pemphigoid Following COVID-19 Vaccination: A Systematic Review. Viruses, 16(12), 1896. https://doi.org/10.3390/v16121896
Vancouver
Martora F, Battista T, Potestio L, Napolitano M, Patruno C, Megna M, et al. Pemphigus and Bullous Pemphigoid Following COVID-19 Vaccination: A Systematic Review. Viruses. 2024;16(12):1896. doi:10.3390/v16121896
BibTeX
@article{Martora2024,
author = {Martora, Fabrizio and Battista, Teresa and Potestio, Luca and Napolitano, Maddalena and Patruno, Cataldo and Megna, Matteo and D'Agostino, Michela},
title = {Pemphigus and Bullous Pemphigoid Following COVID-19 Vaccination: A Systematic Review},
journal = {Viruses},
year = {2024},
volume = {16},
number = {12},
pages = {1896},
doi = {10.3390/v16121896}
}
EUVIMED